Diabetes, Vol 43, Issue 3 403-410, Copyright © 1994 by American Diabetes Association

ARTICLES

Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes

GS Meneilly, E Cheung and H Tuokko
Department of Medicine, University of British Columbia, Vancouver, Canada.

In patients with non-insulin-dependent diabetes mellitus (NIDDM), the risk of severe or fatal hypoglycemia associated with the use of oral agents or insulin increases exponentially with age. We conducted this study with the hypothesis that this increased susceptibility to hypoglycemia is caused by alterations in release of counterregulatory hormones and psychomotor performance during hypoglycemia. Ten healthy nonobese elderly subjects (74 +/- 1 years of age; body mass index, 24.5 +/- 0.6 kg/m2) and 10 nonobese elderly NIDDM subjects (72 +/- 1 years of age; body mass index, 25.6 +/- 0.9 kg/m2) underwent two hyperinsulinemic glucose clamp studies (insulin infusion, 60 mU.m-2 x min-1). In the control study, glucose was maintained at 5 mM for 5 h; in the hypoglycemic study, glucose was kept at 5 mM for 1 h and then lowered in a stepwise fashion to 4.4, 3.8, 3.3, and 2.8 mM in each subsequent hour. At regular intervals in each study, neuropsychological tests were performed, counterregulatory hormones were measured, and a hypoglycemic symptom questionnaire was administered. At a glucose level of 2.8 mM, NIDDM patients had reduced incremental glucagon (normal subjects, 114 +/- 18 ng/l; NIDDM subjects, 63 +/- 9 ng/l; P < 0.05) and growth hormone responses (normal subjects, 13.8 +/- 1.0 micrograms/l; NIDDM subjects, 7.0 +/- 2.0 micrograms/l; P < 0.01) and increased epinephrine (normal subjects, 925 +/- 198 pM; NIDDM subjects, 4175 +/- 824 pM; P < 0.001) and cortisol responses (normal subjects, 291 +/- 49 nM; NIDDM subjects, 524 +/- 92 mM; P < 0.05). Symptom scores were similar in both groups at all levels of glycemia.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. E. Dunning and J. E. Gerich The Role of {alpha}-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications Endocr. Rev., May 1, 2007; 28(3): 253 - 283. [Abstract] [Full Text] [PDF]

				A. J. Sinclair Special Considerations in Older Adults With Diabetes: Meeting the Challenge Diabetes Spectr, October 1, 2006; 19(4): 229 - 233. [Abstract] [Full Text] [PDF]

				V. J. Briscoe and S. N. Davis Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management Clin. Diabetes, July 1, 2006; 24(3): 115 - 121. [Abstract] [Full Text] [PDF]

				S. B. Roberts and I. Rosenberg Nutrition and Aging: Changes in the Regulation of Energy Metabolism With Aging Physiol Rev, April 1, 2006; 86(2): 651 - 667. [Abstract] [Full Text] [PDF]

				N. N. Zammitt and B. M. Frier Hypoglycemia in Type 2 Diabetes: Pathophysiology, frequency, and effects of different treatment modalities Diabetes Care, December 1, 2005; 28(12): 2948 - 2961. [Full Text] [PDF]

				G. H. Murata, R. M. Hoffman, J. H. Shah, C. S. Wendel, and W. C. Duckworth A Probabilistic Model for Predicting Hypoglycemia in Type 2 Diabetes Mellitus: The Diabetes Outcomes in Veterans Study (DOVES) Arch Intern Med, July 12, 2004; 164(13): 1445 - 1450. [Abstract] [Full Text] [PDF]

				R. P. Robertson, D. E.R. Sutherland, E. R. Seaquist, and K. J. Lanz Glucagon, Catecholamine, and Symptom Responses to Hypoglycemia in Living Donors of Pancreas Segments Diabetes, July 1, 2003; 52(7): 1689 - 1694. [Abstract] [Full Text] [PDF]

				H. J. Woerle, C. Meyer, E. M. Popa, P. E. Cryer, and J. E. Gerich Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes: Further Evidence for Hepatorenal Reciprocity Diabetes, June 1, 2003; 52(6): 1386 - 1392. [Abstract] [Full Text] [PDF]

				S. A. Segel, D. S. Paramore, and P. E. Cryer Hypoglycemia-Associated Autonomic Failure in Advanced Type 2 Diabetes Diabetes, March 1, 2002; 51(3): 724 - 733. [Abstract] [Full Text] [PDF]

				H. Huopio, I. Vauhkonen, J. Komulainen, L. Niskanen, T. Otonkoski, and M. Laakso Carriers of an Inactivating {beta}-Cell ATP-Sensitive K+ Channel Mutation Have Normal Glucose Tolerance and Insulin Sensitivity and Appropriate Insulin Secretion Diabetes Care, January 1, 2002; 25(1): 101 - 106. [Abstract] [Full Text] [PDF]

				M. R. Burge, T. A. Sobhy, C. R. Qualls, and D. S. Schade Effect of Short-Term Glucose Control on Glycemic Thresholds for Epinephrine and Hypoglycemic Symptoms J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5471 - 5478. [Abstract] [Full Text] [PDF]

				J. Korosi, C. H.S. McIntosh, R. A. Pederson, H.-U. Demuth, J. F. Habener, R. Gingerich, J. M. Egan, D. Elahi, and G. S. Meneilly Effect of Aging and Diabetes on the Enteroinsular Axis J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2001; 56(9): M575 - 579. [Abstract] [Full Text] [PDF]

				L. Landstedt-Hallin, U. Adamson, and P.-E. Lins Oral Glibenclamide Suppresses Glucagon Secretion during Insulin-Induced Hypoglycemia in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3140 - 3145. [Abstract] [Full Text]

				T. F. Veneman and D. W. Erkelens Hypoglycemia Unawareness in Noninsulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1682 - 1684. [Full Text] [PDF]